These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12501745)

  • 21. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
    Iskander J; Broder K
    Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safe vaccination of children with a virosomal adjuvanted influenza vaccine.
    Künzi V; Dornseiff M; Horwath J; Hartmann K
    Vaccine; 2009 Feb; 27(8):1261-5. PubMed ID: 19114080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance for laboratory-confirmed, influenza-associated hospitalizations--Colorado, 2004-05 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(21):535-7. PubMed ID: 15931157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza surveillance in New Zealand in 2005.
    Huang QS; Lopez L; Adlam B
    N Z Med J; 2007 Jun; 120(1256):U2581. PubMed ID: 17589549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of the trivalent inactivated influenza vaccine among children: a population-based study.
    France EK; Glanz JM; Xu S; Davis RL; Black SB; Shinefield HR; Zangwill KM; Marcy SM; Mullooly JP; Jackson LA; Chen R
    Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1031-6. PubMed ID: 15520339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunogenicity and safety of influenza split vaccine].
    Dong JH; Chang WH; Tian XP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):310-1. PubMed ID: 19642397
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans.
    Moore KM; Duddy A; Braun MM; Platt R; Brown JS
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1137-41. PubMed ID: 18763248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season.
    Orr P;
    Can Commun Dis Rep; 2004 Jun; 30():1-32. PubMed ID: 15239483
    [No Abstract]   [Full Text] [Related]  

  • 30. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
    Tam T; Langley J;
    Can Commun Dis Rep; 2004 Mar; 30():1-5. PubMed ID: 15035403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy.
    Katz MA; Tharmaphornpilas P; Chantra S; Dowell SF; Uyeki T; Lindstrom S; Balish A; Peret TC; Chittaganpitch M; Simmerman JM; Olsen SJ
    Vaccine; 2007 May; 25(19):3827-33. PubMed ID: 17367898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006].
    Labadie J; van Grootheest AC
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2738-42. PubMed ID: 18225798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters.
    Mullooly JP; Crane B; Chun C
    Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute neurological events associated with influenza vaccination: are the WHO criteria for assessing causality adequate?
    Kavadas FD; Bitnun A; MacGregor D; Heurter H; Ford Jones EL
    Scand J Infect Dis; 2008; 40(6-7):565-70. PubMed ID: 18584549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Children hospitalized with influenza during the 2006-2007 season: a report from the Canadian Immunization Monitoring Program, Active (IMPACT).
    Burton C; Vaudry W; Moore D; Scheifele D; Bettinger J; Halperin S; Tam T; Law B;
    Can Commun Dis Rep; 2008 Dec; 34(12):17-32. PubMed ID: 19368059
    [No Abstract]   [Full Text] [Related]  

  • 37. Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity.
    Giezeman KM; Nauta J; de Bruijn IA; Palache AM
    Vaccine; 2009 Apr; 27(18):2414-7. PubMed ID: 19368782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long time trends in influenza-like illness and associated determinants in The Netherlands.
    Dijkstra F; Donker GA; Wilbrink B; Van Gageldonk-Lafeber AB; Van Der Sande MA
    Epidemiol Infect; 2009 Apr; 137(4):473-9. PubMed ID: 18789176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.